BIIB
BIOGEN INC.
NASDAQ · Healthcare · Drug Manufacturers - General · US
$250.91
+0.79%Leverage
- Debt / equity
- 0.41x
- Net debt / equity
- 0.34x
- Debt / assets
- 0.24x
- Debt / EBITDA
- 5.39x
- Net debt / EBITDA
- 4.49x
Liquidity & coverage
- Current ratio
- 1.95x
- Quick ratio
- 1.37x
- Cash ratio
- 0.33x
- Interest coverage
- 2.58x
- EBITDA / interest
- 4.75x
- Working capital
- $3.7B
Cash & dividend
- FCF / debt
- 0.30x
- Cash flow / debt
- 0.29x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026